These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7554775)

  • 1. Prevention of macrovascular disease: absolute proof or absolute risk?
    Durrington PN
    Diabet Med; 1995 Jul; 12(7):561-2. PubMed ID: 7554775
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting CHD risk in patients with diabetes.
    Chowdhury T; Lasker SS
    Diabet Med; 2002 Jan; 19(1):83-4. PubMed ID: 11869313
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of dyslipidemia in adults with diabetes.
    Haffner SM
    Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients.
    Torremocha F; Hadjadj S; Carrié F; Rosenberg T; Herpin D; Maréchaud R
    Diabetes Metab; 2001 Feb; 27(1):49-57. PubMed ID: 11240446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward risk factor control for all patients with diabetes.
    Whitehouse F
    Diabetes Care; 1992 Nov; 15(11):1818-20. PubMed ID: 1468321
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes and lipids--a conundrum.
    Begley JP; Kerr D
    Diabet Med; 2000 Aug; 17(8):623-4. PubMed ID: 11073186
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes and coronary heart disease: the role of hyperlipidemia.
    Betteridge DJ
    J Diabet Complications; 1990; 4(2):53-6. PubMed ID: 2145299
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].
    Brath H; Wascher TC; Kästenbauer T; Toplak H
    MMW Fortschr Med; 2012 Jun; 154 Suppl 2():41-7. PubMed ID: 23424754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute benefit from cholesterol lowering in diabetic patients with coronary heart disease.
    Strandberg TE
    Diabetes Care; 1997 Sep; 20(9):1495-6. PubMed ID: 9283807
    [No Abstract]   [Full Text] [Related]  

  • 10. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes.
    Liu J; Sempos C; Donahue RP; Dorn J; Trevisan M; Grundy SM
    Diabetes Care; 2005 Aug; 28(8):1916-21. PubMed ID: 16043732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of improved glycemic control on complications in type 2 diabetes.
    Gaster B; Hirsch IB
    Arch Intern Med; 1998 Jan; 158(2):134-40. PubMed ID: 9448551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The case for tight control in diabetes.
    Hollander P
    Postgrad Med; 1984 Mar; 75(4):80-7. PubMed ID: 6701135
    [No Abstract]   [Full Text] [Related]  

  • 13. Looking at the world through LDL-cholesterol-colored glasses.
    Reaven GM
    J Nutr; 1986 Jul; 116(7):1143-7. PubMed ID: 3528426
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term intervention trials about diabetic complications in the west].
    Miwa S; Kawamori R
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():35-43. PubMed ID: 12430205
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting dyslipidemia--the key to CHD risk reduction in the diabetic population?
    Betteridge DJ; Rosenson RS
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S1-2. PubMed ID: 15953502
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.
    Turner RC; Millns H; Holman RR
    Diabetologia; 1997 Jul; 40 Suppl 2():S121-2. PubMed ID: 9248716
    [No Abstract]   [Full Text] [Related]  

  • 17. Inpatient diabetes control: rationale.
    Bloomgarden ZT
    Diabetes Care; 2004 Aug; 27(8):2074-80. PubMed ID: 15277444
    [No Abstract]   [Full Text] [Related]  

  • 18. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?
    Drexel H; Aczel S; Marte T; Benzer W; Langer P; Moll W; Saely CH
    Diabetes Care; 2005 Jan; 28(1):101-7. PubMed ID: 15616241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting CHD risk in patients with diabetes mellitus.
    Yeo WW; Yeo KR
    Diabet Med; 2001 May; 18(5):341-4. PubMed ID: 11472442
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
    Haffner SM
    Diabetes Care; 1999 Apr; 22 Suppl 3():C54-6. PubMed ID: 10189563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.